Fatigue · systemic lupus erythematosus
1 finding from 1 review
Disease activity · systemic lupus erythematosus
1 finding from 1 review
Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) · systemic lupus erythematosus
1 finding from 1 review
Fatigue · systemic lupus erythematosus
1 finding from 1 review
Disease activity · systemic lupus erythematosus
1 finding from 1 review
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · systemic lupus erythematosus
1 finding from 1 review
Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) · systemic lupus erythematosus
1 finding from 1 review
Fatigue · systemic lupus erythematosus
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
FVC · people with systemic sclerosis
Autologous myeloablative selective HSCT showed no clear difference in interstitial lung disease – FVC (% predicted) A lower percentage… compared with cyclophosphamide (moderate certainty).
1 finding from 1 review
Interstitial lung disease – FVC % predicted A lower percentage represents worse lung disease. The study incorporated a ≥ 15% chance · people with systemic sclerosis
1 finding from 1 review
Interstitial lung disease – FVC % predicted A lower percentage represents worse lung disease · people with systemic sclerosis
1 finding from 1 review
Radiographic joint changes · Patients with osteoarthritis of the knee or hip
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Patients with shoulder pain
1 finding from 1 review
Intervention not reported
Change in pain Visual Analog Scale (VAS) at 12 weeks (0 to 10 scale; lower score means less pain) · people with rheumatoid arthritis
It is very uncertain whether the intervention changes change in pain Visual Analog Scale (VAS) at 12 weeks (0 to 10 scale;… (very low certainty).
1 finding from 1 review
Intervention not reported
Change in measure of disease activity Disease Activity Score (DAS‐28‐ESR) at 12 weeks (0 to 10 score; lower score means less disease activity) · people with rheumatoid arthritis
It is very uncertain whether the intervention changes change in measure of disease activity Disease Activity Score… (very low certainty).
1 finding from 1 review
Intervention not reported
Change in function Health Assessment Questionnaire (HAQ) at 12 weeks (0 to 3 score; lower score means better function) · people with rheumatoid arthritis
It is very uncertain whether the intervention changes change in function Health Assessment Questionnaire (HAQ) at 12 weeks… (very low certainty).
1 finding from 1 review
Intervention not reported
Physical performance: self‐report questionnaires Physical function subscale from the QUALEFFO‐41 Scale from 0 to 100 Lower scores indicate better physical function · individuals with osteoporotic vertebral fracture
1 finding from 1 review